| |
BIO CEO & Investor Conference
|
| With founder/CEOs Michael Morrissey (Exelixis), Michael Chapman (Thrombo Therapeutics), Alan Cash (Metvital), Zachary Hornby (Boundless Bio), Carlos de Sousa (Immunicum), John Orwin (Atreca), Eric Johnston (CTO, Sigrid Therapeutics), Amy Abernethy (Principal Deputy Commissioner, FDA). |
| Marriott Marquis, 1535 Broadway |
|
Feb 10 (Mon) , 2020 @ 09:00 AM
| |
Not Known |
|
|
|
|
|
|
|
|
| |
| DETAILS |
|
Now in its 22nd year, the BIO CEO & Investor Conference is one of the largest independent investor conferences focused on established & emerging publicly traded & select private biotech companies. Experience the best of biotech with two days of productive partnering meetings with institutional & early-stage investors, industry analysts, & senior biotechnology executives, in one location.
Why Attend
Now in its 22nd year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established & emerging publicly traded & select private biotech companies. Experience the best of biotech with two days of productive partnering meetings with institutional investors, industry analysts, & senior biotechnology executives, in one location.
Why Companies Attend
For many, the 2020 BIO CEO & Investor Conference will be the first major investor event after JPM Week. Experience the best of biotech & maintain your deal-making momentum with two-days of productive BIO One-on-One Partnering meetings, in one location.
Why Investors Attend
Evaluate fresh investment opportunities & attend candid panel discussions with leading industry experts on the latest therapies in development & other issues affecting the investment climate.
|
|
|
|
|
|
|
|
